<i>BRCA1</i> and Metastasis: Outcome of Defective DNA Repair
Heritable mutations in <i>BRCA1</i> and <i>BRCA2</i> genes are a major risk factor for breast and ovarian cancer. Inherited mutations in <i>BRCA1</i> increase the risk of developing breast cancers by up to 72% and ovarian cancers by up to 69%, when compared to ind...
Main Authors: | Rehna Krishnan, Parasvi S. Patel, Razqallah Hakem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/1/108 |
Similar Items
-
Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors
by: Lisa Kinget, et al.
Published: (2021-08-01) -
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
by: Sidrah Shah, et al.
Published: (2021-11-01) -
Roles of the PARP Inhibitor in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment
by: Takahiro Inoue, et al.
Published: (2023-05-01) -
<em>BRCA</em>-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
by: Naomie Devico Marciano, et al.
Published: (2022-05-01) -
Mutations of <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i> Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
by: Matvey M. Tsyganov, et al.
Published: (2023-07-01)